| 04/10/19 | 13:07:40 | 4 Oct 2019 | | Second Price Monitoring Extn | RNS |
| 04/10/19 | 13:02:16 | 4 Oct 2019 | | Price Monitoring Extension | RNS |
| 01/10/19 | 17:40:42 | 1 Oct 2019 | | Second Price Monitoring Extn | RNS |
| 01/10/19 | 17:35:22 | 1 Oct 2019 | | Price Monitoring Extension | RNS |
| 30/09/19 | 08:00:06 | 30 Sept 2019 | | Interim Results Announcement | RNS |
| 18/09/19 | 17:35:19 | 18 Sept 2019 | | Price Monitoring Extension | RNS |
| 04/07/19 | 08:00:06 | 4 Jul 2019 | | TR-1: notification of major holdings | RNS |
| 02/07/19 | 16:33:11 | 2 Jul 2019 | | TR-1: notification of major holdings | RNS |
| 28/06/19 | 08:00:05 | 28 Jun 2019 | | Update on Lupuzor | RNS |
| 27/06/19 | 14:38:52 | 27 Jun 2019 | | 2019 Annual General Meeting | RNS |
| 26/06/19 | 08:00:06 | 26 Jun 2019 | | Subscription to raise £2.66 million | RNS |
| 04/06/19 | 08:00:11 | 4 Jun 2019 | | Notice of AGM and posting of Report & Accounts | RNS |
| 24/05/19 | 08:00:05 | 24 May 2019 | | FINAL RESULTS | RNS |
| 07/05/19 | 09:15:26 | 7 May 2019 | | Corporate Update - Replacement | RNS |
| 01/04/19 | 08:00:06 | 1 Apr 2019 | | Update on Nucant Cancer Programme | RNS |
| 14/03/19 | 07:00:12 | 14 Mar 2019 | | Corporate Update | RNS |
| 26/02/19 | 07:00:27 | 26 Feb 2019 | | Technology review published-Nature Communications | RNS |
| 31/12/18 | 07:00:07 | 31 Dec 2018 | | Clinical Development Collaboration with Incanthera | RNS |
| 21/12/18 | 16:41:02 | 21 Dec 2018 | | Second Price Monitoring Extn | RNS |
| 21/12/18 | 16:36:19 | 21 Dec 2018 | | Price Monitoring Extension | RNS |
| 20/12/18 | 16:35:48 | 20 Dec 2018 | | Price Monitoring Extension | RNS |
| 17/12/18 | 07:00:06 | 17 Dec 2018 | | Appointment of Nominated Adviser | RNS |
| 07/12/18 | 07:00:05 | 7 Dec 2018 | | Update on Corporate Activities | RNS |
| 29/11/18 | 16:40:41 | 29 Nov 2018 | | Second Price Monitoring Extn | RNS |
| 29/11/18 | 16:35:14 | 29 Nov 2018 | | Price Monitoring Extension | RNS |
| 28/11/18 | 16:40:49 | 28 Nov 2018 | | Second Price Monitoring Extn | RNS |
| 28/11/18 | 16:35:13 | 28 Nov 2018 | | Price Monitoring Extension | RNS |
| 23/11/18 | 16:40:48 | 23 Nov 2018 | | Second Price Monitoring Extn | RNS |
| 23/11/18 | 16:35:39 | 23 Nov 2018 | | Price Monitoring Extension | RNS |
| 21/11/18 | 16:40:39 | 21 Nov 2018 | | Second Price Monitoring Extn | RNS |
| 21/11/18 | 16:35:37 | 21 Nov 2018 | | Price Monitoring Extension | RNS |
| 07/11/18 | 16:35:16 | 7 Nov 2018 | | Price Monitoring Extension | RNS |
| 01/11/18 | 13:38:00 | 1 Nov 2018 | | Nominated Adviser Status | RNS |
| 26/09/18 | 08:00:02 | 26 Sept 2018 | | Interim Results | RNS |
| 19/09/18 | 08:00:05 | 19 Sept 2018 | | Appointment of Joint Brokers | RNS |
| 07/09/18 | 08:00:03 | 7 Sept 2018 | | Corporate Update | RNS |
| 10/07/18 | 17:40:26 | 10 Jul 2018 | | Second Price Monitoring Extn | RNS |
| 10/07/18 | 17:35:13 | 10 Jul 2018 | | Price Monitoring Extension | RNS |
| 14/06/18 | 08:00:02 | 14 Jun 2018 | | Results of CIDP Pre-Clinical Data | RNS |
| 06/06/18 | 08:00:13 | 6 Jun 2018 | | Notice of AGM & Posting of Annual Report | RNS |
| 29/05/18 | 08:00:15 | 29 May 2018 | | Update on Pivotal Phase III Trial of Lupuzor | RNS |
| 29/05/18 | 08:00:14 | 29 May 2018 | | Final Results | RNS |
| 20/04/18 | 09:24:06 | 20 Apr 2018 | | Holding(s) in Company | RNS |
| 17/04/18 | 08:00:05 | 17 Apr 2018 | | Topline results of Lupuzor Pivotal Phase III Trial | RNS |
| 28/03/18 | 08:00:07 | 28 Mar 2018 | | Appointment of Joint Broker | RNS |
| 23/03/18 | 07:00:04 | 23 Mar 2018 | | Lupuzor Pivotal Phase III Study Update | RNS |
| 05/03/18 | 16:13:38 | 5 Mar 2018 | | AIM Notice (17) | RNS |
| 15/02/18 | 07:00:06 | 15 Feb 2018 | | London Investor Evening | RNS |
| 09/02/18 | 14:00:02 | 9 Feb 2018 | | Holding(s) in Company | RNS |
| 07/02/18 | 09:35:46 | 7 Feb 2018 | | Holding(s) in Company | RNS |
